Resverlogix Corp. (RVX)

Currency in CAD
0.095
+0.005(+5.56%)
Real-time Data·
RVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0950.100
52 wk Range
0.0450.300
Key Statistics
Bid/Ask
0.09 / 0.10
Prev. Close
0.09
Open
0.095
Day's Range
0.095-0.1
52 wk Range
0.045-0.3
Volume
45.17K
Average Volume (3m)
28.94K
1-Year Change
90%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RVX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Resverlogix Corp. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Jul 01, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RVX Income Statement

Compare RVX to Peers and Sector

Metrics to compare
RVX
Peers
Sector
Relationship
P/E Ratio
−3.5x−4.9x−0.4x
PEG Ratio
−0.06−0.040.00
Price/Book
−0.2x1.8x2.6x
Price / LTM Sales
-31.9x3.1x
Upside (Analyst Target)
-316.7%48.3%
Fair Value Upside
Unlock−13.9%6.1%Unlock

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
85.29M24.80%7.68M
Public Companies & Retail Investors
258.56M75.20%23.27M
Total
343.84M100.00%30.95M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.24.80%85,286,5247,676

FAQ

What Is the Resverlogix Corp. (RVX) Stock Price Today?

The Resverlogix Corp. stock price today is 0.095 CAD.

What Stock Exchange Does Resverlogix Corp. Trade On?

Resverlogix Corp. is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Resverlogix Corp.?

The stock symbol for Resverlogix Corp. is "RVX."

What Is the Resverlogix Corp. Market Cap?

As of today, Resverlogix Corp. market cap is 32.660M CAD.

What Is Resverlogix Corp.'s Earnings Per Share (TTM)?

The Resverlogix Corp. EPS (TTM) is -0.022.

When Is the Next Resverlogix Corp. Earnings Date?

Resverlogix Corp. will release its next earnings report on Jul 01, 2026.

From a Technical Analysis Perspective, Is RVX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Resverlogix Corp. Stock Split?

Resverlogix Corp. has split 0 times.

How Many Employees Does Resverlogix Corp. Have?

Resverlogix Corp. has 19 employees.

What is the current trading status of Resverlogix Corp. (RVX)?

As of Jul 07, 2026, Resverlogix Corp. (RVX) is trading at a price of 0.095 CAD, with a previous close of 0.090 CAD. The stock has fluctuated within a day range of 0.095 CAD to 0.100 CAD, while its 52-week range spans from 0.045 CAD to 0.300 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.